ACTINIUM PHARMACEUTICALS, INC. (ATNM)
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates
Lithium Ionic Provides Bi-Weekly MCTO Status Update
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
Regal Rexnord Names Mark Klossner EVP & President, Industrial Powertrain Solutions (IPS), Jerry Morton to Retire as EVP & President, IPS
Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
Anfield Energy Inc. Completes Phase One Surface Construction at Velvet-Wood Project
Ollie’s Bargain Outlet Holdings, Inc. Appoints Jared Shure as Senior Vice President, General Counsel and Corporate Secretary
Canadian Solar Releases 2025 Corporate Sustainability Report
C1 Fund Inc. (NYSE: CFND) Announces First Quarter 2026 Results